Further, at the completion of the clinical trial which have already taken place or will take place, “if the vaccines look safe, then they could be available to use in November”.
The organization also announced today that the products made based to blood of people who have survived Ebola, can be used for its treatment.

The amount of the various experimental medicine for the virus are extremely limited and wouldn’t be sufficient not even for the next few months, but when it comes to the vaccines the situation seems “slightly better” according to a statement of the WHO.